{
    "clinical_study": {
        "@rank": "41937", 
        "arm_group": [
            {
                "arm_group_label": "Part A (two-period cross-over), Arm 1", 
                "arm_group_type": "Experimental", 
                "description": "Atorvastatin"
            }, 
            {
                "arm_group_label": "Part A (two-period cross-over), Arm 2", 
                "arm_group_type": "Placebo Comparator", 
                "description": "Placebo"
            }, 
            {
                "arm_group_label": "Part B, Arm 1", 
                "arm_group_type": "Experimental", 
                "description": "Evolocumab"
            }, 
            {
                "arm_group_label": "Part B, Arm 2", 
                "arm_group_type": "Active Comparator", 
                "description": "Ezetimbe"
            }, 
            {
                "arm_group_label": "Part C, Arm 1", 
                "arm_group_type": "Experimental", 
                "description": "Evolocumab"
            }
        ], 
        "brief_summary": {
            "textblock": "The study is divided into 3 parts (A, B, C). Part A is a double-blind, placebo-controlled,\n      two-period cross-over rechallenge of atorvastatin 20 mg. Part B is a 24-week double-blind,\n      double-dummy comparison of evolocumab and ezetimibe. Part C is a 2-year open-label\n      evolocumab extension. The primary hypothesis is that evolocumab will be well tolerated and\n      will result in greater reduction of LDL-C than ezetimibe, defined by the mean percent change\n      from baseline at Weeks 22 and 24 of Part B and percent change from baseline at Week 24 of\n      Part B, in statin-intolerant hypercholesterolemic subjects."
        }, 
        "brief_title": "Goal Achievement After Utilizing an Anti-PCSK9 Antibody in Statin Intolerant Subjects-3", 
        "completion_date": {
            "#text": "April 2018", 
            "@type": "Anticipated"
        }, 
        "condition": "Hyperlipidemia", 
        "condition_browse": {
            "mesh_term": "Hyperlipidemias"
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Male or female \u2265 18 to \u2264 80 years of age\n\n          -  Subject not at LDL-C goal\n\n          -  History of statin intolerance\n\n          -  Lipid lowering therapy has been stable prior to enrolment for at least 4 weeks\n\n          -  Fasting triglycerides \u2264 400 mg/dL\n\n        Exclusion Criteria:\n\n          -  NYHA III or IV heart failure\n\n          -  Uncontrolled cardiac arrhythmia\n\n          -  Uncontrolled hypertension\n\n          -  Type 1 diabetes\n\n          -  Poorly controlled type 2 diabetes\n\n          -  Uncontrolled hypothyroidism or hyperthyroidism"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "80 Years", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "500", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "November 8, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01984424", 
            "org_study_id": "20120332"
        }, 
        "intervention": [
            {
                "arm_group_label": [
                    "Part A (two-period cross-over), Arm 1", 
                    "Part A (two-period cross-over), Arm 2"
                ], 
                "description": "Subjects will receive atorvastatin daily", 
                "intervention_name": "Part A, Atorvastatin", 
                "intervention_type": "Drug"
            }, 
            {
                "arm_group_label": [
                    "Part A (two-period cross-over), Arm 1", 
                    "Part A (two-period cross-over), Arm 2"
                ], 
                "description": "Subjects will receive oral placebo daily", 
                "intervention_name": "Part A, Placebo (administered orally)", 
                "intervention_type": "Other"
            }, 
            {
                "arm_group_label": "Part B, Arm 1", 
                "description": "Subjects will receive subcutaneous evolocumab every month", 
                "intervention_name": "Part B, Evolocumab", 
                "intervention_type": "Drug"
            }, 
            {
                "arm_group_label": "Part B, Arm 1", 
                "description": "Subjects will receive oral placebo every day", 
                "intervention_name": "Part B, Placebo (administered orally)", 
                "intervention_type": "Other"
            }, 
            {
                "arm_group_label": "Part B, Arm 2", 
                "description": "Subjects will receive oral ezetimibe daily", 
                "intervention_name": "Part B, Ezetimibe", 
                "intervention_type": "Drug"
            }, 
            {
                "arm_group_label": "Part B, Arm 2", 
                "description": "Subjects will receive subcutaneous placebo every month.", 
                "intervention_name": "Part B, Placebo (administered subcutaneously)", 
                "intervention_type": "Other"
            }, 
            {
                "arm_group_label": "Part C, Arm 1", 
                "description": "Subjects will receive subcutaneous evolocumab every 2 weeks or monthly", 
                "intervention_name": "Part C, Evolocumab", 
                "intervention_type": "Drug"
            }
        ], 
        "intervention_browse": {
            "mesh_term": [
                "Atorvastatin", 
                "Hydroxymethylglutaryl-CoA Reductase Inhibitors", 
                "Ezetimibe"
            ]
        }, 
        "is_fda_regulated": "Yes", 
        "is_section_801": "No", 
        "keyword": "High Cholesterol, Treatment for high cholesterol, Lowering cholesterol, Lowering high cholesterol, Hypercholesterolemia", 
        "lastchanged_date": "May 28, 2014", 
        "link": {
            "description": "AmgenTrials clinical trials website", 
            "url": "http://www.amgentrials.com"
        }, 
        "location": [
            {
                "facility": {
                    "address": {
                        "city": "Beverly Hills", 
                        "country": "United States", 
                        "state": "California", 
                        "zip": "90211"
                    }, 
                    "name": "Research Site"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Huntington Beach", 
                        "country": "United States", 
                        "state": "California", 
                        "zip": "92648"
                    }, 
                    "name": "Research Site"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Sterling", 
                        "country": "United States", 
                        "state": "Illinois", 
                        "zip": "61081"
                    }, 
                    "name": "Research Site"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Kansas City", 
                        "country": "United States", 
                        "state": "Kansas", 
                        "zip": "66160"
                    }, 
                    "name": "Research Site"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Baltimore", 
                        "country": "United States", 
                        "state": "Maryland", 
                        "zip": "21201"
                    }, 
                    "name": "Research Site"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Towson", 
                        "country": "United States", 
                        "state": "Maryland", 
                        "zip": "21204"
                    }, 
                    "name": "Research Site"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Ann Arbor", 
                        "country": "United States", 
                        "state": "Michigan", 
                        "zip": "48106"
                    }, 
                    "name": "Research Site"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "New York", 
                        "country": "United States", 
                        "state": "New York", 
                        "zip": "10029"
                    }, 
                    "name": "Research Site"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "York", 
                        "country": "United States", 
                        "state": "Pennsylvania", 
                        "zip": "17405"
                    }, 
                    "name": "Research Site"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Charleston", 
                        "country": "United States", 
                        "state": "South Carolina", 
                        "zip": "29425"
                    }, 
                    "name": "Research Site"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Houston", 
                        "country": "United States", 
                        "state": "Texas", 
                        "zip": "77030"
                    }, 
                    "name": "Research Site"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Camperdown", 
                        "country": "Australia", 
                        "state": "New South Wales", 
                        "zip": "2015"
                    }, 
                    "name": "Research Site"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Woolloongabba", 
                        "country": "Australia", 
                        "state": "Queensland", 
                        "zip": "4102"
                    }, 
                    "name": "Research Site"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Ashford", 
                        "country": "Australia", 
                        "state": "South Australia", 
                        "zip": "5035"
                    }, 
                    "name": "Research Site"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Vancouver", 
                        "country": "Canada", 
                        "state": "British Columbia", 
                        "zip": "V5Z 1M9"
                    }, 
                    "name": "Research Site"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Hamilton", 
                        "country": "Canada", 
                        "state": "Ontario", 
                        "zip": "L8L 2X2"
                    }, 
                    "name": "Research Site"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "London", 
                        "country": "Canada", 
                        "state": "Ontario", 
                        "zip": "N6A 4V2"
                    }, 
                    "name": "Research Site"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Peterborough", 
                        "country": "Canada", 
                        "state": "Ontario", 
                        "zip": "K9J 0B2"
                    }, 
                    "name": "Research Site"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "St-Charles-Borromee", 
                        "country": "Canada", 
                        "state": "Quebec", 
                        "zip": "J6E 6J2"
                    }, 
                    "name": "Research Site"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Quebec", 
                        "country": "Canada", 
                        "zip": "G1V 4M6"
                    }, 
                    "name": "Research Site"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Praha 2", 
                        "country": "Czech Republic", 
                        "zip": "128 08"
                    }, 
                    "name": "Research Site"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Praha 4", 
                        "country": "Czech Republic", 
                        "zip": "140 21"
                    }, 
                    "name": "Research Site"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Glostrup", 
                        "country": "Denmark", 
                        "zip": "2600"
                    }, 
                    "name": "Research Site"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Nantes Cedex 1", 
                        "country": "France", 
                        "zip": "44093"
                    }, 
                    "name": "Research Site"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Paris Cedex 13", 
                        "country": "France", 
                        "zip": "75651"
                    }, 
                    "name": "Research Site"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Berlin", 
                        "country": "Germany", 
                        "zip": "13353"
                    }, 
                    "name": "Research Site"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "K\u00f6ln", 
                        "country": "Germany", 
                        "zip": "50937"
                    }, 
                    "name": "Research Site"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "M\u00fcnchen", 
                        "country": "Germany", 
                        "zip": "80638"
                    }, 
                    "name": "Research Site"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Pisa", 
                        "country": "Italy", 
                        "zip": "56124"
                    }, 
                    "name": "Research Site"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Amsterdam", 
                        "country": "Netherlands", 
                        "zip": "1105 AZ"
                    }, 
                    "name": "Research Site"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Oslo", 
                        "country": "Norway", 
                        "zip": "0373"
                    }, 
                    "name": "Research Site"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "\u00c5lesund", 
                        "country": "Norway", 
                        "zip": "6003"
                    }, 
                    "name": "Research Site"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Birmingham", 
                        "country": "United Kingdom", 
                        "zip": "B15 2TH"
                    }, 
                    "name": "Research Site"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Glasgow", 
                        "country": "United Kingdom", 
                        "zip": "G12 8TA"
                    }, 
                    "name": "Research Site"
                }, 
                "status": "Recruiting"
            }
        ], 
        "location_countries": {
            "country": [
                "United States", 
                "Australia", 
                "Canada", 
                "Czech Republic", 
                "Denmark", 
                "France", 
                "Germany", 
                "Italy", 
                "Netherlands", 
                "Norway", 
                "United Kingdom"
            ]
        }, 
        "number_of_arms": "5", 
        "official_title": "A Double-blind, Randomized, Multicenter Study to Evaluate the Safety and Efficacy of Evolocumab, Compared With Ezetimibe, in Hypercholesterolemic Subjects Unable to Tolerate an Effective Dose of a HMG-CoA Reductase Inhibitor Due to Muscle Related Side Effects", 
        "overall_contact": {
            "last_name": "Amgen Call Center", 
            "phone": "866-572-6436"
        }, 
        "overall_official": {
            "affiliation": "Amgen", 
            "last_name": "MD", 
            "role": "Study Director"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": [
                "Netherlands: Centrale Commissie Mensgebonden Onderzoek (CCMO)", 
                "Norway: Norwegian Medicines Agency (Statens legemiddelverk)", 
                "Czech Republic: State Institute for Drug Control (SUKL)", 
                "Italy: National Monitoring Centre for Clinical Trials - Ministry of Health", 
                "Australia: Department of Health and Ageing Therapeutic Goods Administration", 
                "France: Afssaps - Agence fran\u00e7aise de s\u00e9curit\u00e9 sanitaire des produits de sant\u00e9 (Saint-Denis)", 
                "Germany: Paul-Ehrlich-Institute", 
                "Denmark: Danish Health and Medicines Authority", 
                "South Africa: Medicines Control Council", 
                "United Kingdom: Medicines and Healthcare Products Regulatory Agency", 
                "Canada: Health Canada", 
                "United States: Food and Drug Administration"
            ], 
            "has_dmc": "Yes"
        }, 
        "phase": "Phase 3", 
        "primary_completion_date": {
            "#text": "October 2017", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": [
            {
                "description": "Mean percent change from baseline in low density lipoprotein-cholesterol", 
                "measure": "Mean percent change from baseline in low density lipoprotein-cholesterol", 
                "safety_issue": "No", 
                "time_frame": "22 and 24 Weeks"
            }, 
            {
                "description": "Percent change from baseline in low density lipoprotein-cholesterol", 
                "measure": "Percent change from baseline in low density lipoprotein-cholesterol", 
                "safety_issue": "No", 
                "time_frame": "24 Weeks"
            }
        ], 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01984424"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": [
            {
                "description": "Mean change from baseline in low density lipoprotein-cholesterol", 
                "measure": "Mean change from baseline in low density lipoprotein-cholesterol", 
                "safety_issue": "No", 
                "time_frame": "22 and 24 Weeks"
            }, 
            {
                "description": "Change from baseline in low density lipoprotein-cholesterol", 
                "measure": "Change from baseline in low density lipoprotein-cholesterol", 
                "safety_issue": "No", 
                "time_frame": "24 Weeks"
            }, 
            {
                "description": "Mean low density lipoprotein-cholesterol response (low density lipoprotein-cholesterol < 70 mg/dL [1.8 mmol/L])", 
                "measure": "Mean low density lipoprotein-cholesterol response (low density lipoprotein-cholesterol < 70 mg/dL [1.8 mmol/L])", 
                "safety_issue": "No", 
                "time_frame": "22 and 24 Weeks"
            }, 
            {
                "description": "Low density lipoprotein-cholesterol response (low density lipoprotein-cholesterol < 70 mg/dL [1.8 mmol/L])", 
                "measure": "Low density lipoprotein-cholesterol response (low density lipoprotein-cholesterol < 70 mg/dL [1.8 mmol/L])", 
                "safety_issue": "No", 
                "time_frame": "24 Weeks"
            }, 
            {
                "description": "Mean percent change from baseline in total cholesterol", 
                "measure": "Mean percent change from baseline in total cholesterol", 
                "safety_issue": "No", 
                "time_frame": "22 and 24 Weeks"
            }, 
            {
                "description": "Percent change from baseline in total cholesterol", 
                "measure": "Percent change from baseline in total cholesterol", 
                "safety_issue": "No", 
                "time_frame": "24 Weeks"
            }, 
            {
                "description": "Mean percent change from baseline in non-high density lipoprotein-cholesterol", 
                "measure": "Mean percent change from baseline in non-high density lipoprotein-cholesterol", 
                "safety_issue": "No", 
                "time_frame": "22 and 24 Weeks"
            }, 
            {
                "description": "Percent change from baseline in non-high density lipoprotein-cholesterol", 
                "measure": "Percent change from baseline in non-high density lipoprotein-cholesterol", 
                "safety_issue": "No", 
                "time_frame": "24 Weeks"
            }, 
            {
                "description": "Mean percent change from baseline in apolipoprotein B", 
                "measure": "Mean percent change from baseline in apolipoprotein B", 
                "safety_issue": "No", 
                "time_frame": "22 and 24 Weeks"
            }, 
            {
                "description": "Percent change from baseline in apolipoprotein B", 
                "measure": "Percent change from baseline in apolipoprotein B", 
                "safety_issue": "No", 
                "time_frame": "24 Weeks"
            }, 
            {
                "description": "Mean percent change from baseline in the total cholesterol/high density lipoprotein-cholesterol ratio", 
                "measure": "Mean percent change from baseline in the total cholesterol/high density lipoprotein-cholesterol ratio", 
                "safety_issue": "No", 
                "time_frame": "22 and 24 Weeks"
            }, 
            {
                "description": "Percent change from baseline in the total cholesterol/high density lipoprotein-cholesterol ratio", 
                "measure": "Percent change from baseline in the total cholesterol/high density lipoprotein-cholesterol ratio", 
                "safety_issue": "No", 
                "time_frame": "24 Weeks"
            }, 
            {
                "description": "Mean percent change from baseline in apolipoprotein B/apolipoprotein A1 ratio", 
                "measure": "Mean percent change from baseline in apolipoprotein B/apolipoprotein A1 ratio", 
                "safety_issue": "No", 
                "time_frame": "22 and 24 Weeks"
            }, 
            {
                "description": "Percent change from baseline in apolipoprotein B/apolipoprotein A1 ratio", 
                "measure": "Percent change from baseline in apolipoprotein B/apolipoprotein A1 ratio", 
                "safety_issue": "No", 
                "time_frame": "24 Weeks"
            }, 
            {
                "description": "Mean percent change from baseline in lipoprotein (a)", 
                "measure": "Mean percent change from baseline in lipoprotein (a)", 
                "safety_issue": "No", 
                "time_frame": "22 and 24 Weeks"
            }, 
            {
                "description": "Percent change from baseline in lipoprotein (a)", 
                "measure": "Percent change from baseline in lipoprotein (a)", 
                "safety_issue": "No", 
                "time_frame": "24 Weeks"
            }, 
            {
                "description": "Mean percent change from baseline in triglycerides", 
                "measure": "Mean percent change from baseline in triglycerides", 
                "safety_issue": "No", 
                "time_frame": "22 and 24 Weeks"
            }, 
            {
                "description": "Percent change from baseline in triglycerides", 
                "measure": "Percent change from baseline in triglycerides", 
                "safety_issue": "No", 
                "time_frame": "24 Weeks"
            }, 
            {
                "description": "Mean percent change from baseline in high density lipoprotein-cholesterol", 
                "measure": "Mean percent change from baseline in high density lipoprotein-cholesterol", 
                "safety_issue": "No", 
                "time_frame": "22 and 24 Weeks"
            }, 
            {
                "description": "Percent change from baseline in high density lipoprotein-cholesterol", 
                "measure": "Percent change from baseline in high density lipoprotein-cholesterol", 
                "safety_issue": "No", 
                "time_frame": "24 Weeks"
            }, 
            {
                "description": "Mean percent change from baseline in very low density lipoprotein-cholesterol", 
                "measure": "Mean percent change from baseline in very low density lipoprotein-cholesterol", 
                "safety_issue": "No", 
                "time_frame": "22 and 24 Weeks"
            }, 
            {
                "description": "Percent change from baseline in very low density lipoprotein-cholesterol", 
                "measure": "Percent change from baseline in very low density lipoprotein-cholesterol", 
                "safety_issue": "No", 
                "time_frame": "24 Weeks"
            }
        ], 
        "source": "Amgen", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Amgen", 
                "agency_class": "Industry"
            }
        }, 
        "start_date": "December 2013", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor), Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "May 2014"
    }
}